EBIT Margin: Earnings before interest and taxes as a portion of total revenues. Calculated as: EBIT / Total Revenues
bioAffinity Technologies, Inc. (BIAF) had EBIT Margin of -196.94% for the most recently reported fiscal quarter, ending 2025-12-31.
| Income Statement Financials | |
$1.59M |
|
$-3.14M |
|
$0.90M |
|
$0.69M |
|
$4.73M |
|
$-3.14M |
|
$0.00M |
|
$-3.13M |
|
$-3.13M |
|
$-3.14M |
|
$-3.14M |
|
$-3.14M |
|
$-3.14M |
|
$-3.14M |
|
$-3.01M |
|
1.72M |
|
1.72M |
|
$5.99 |
|
$5.99 |
|
| Balance Sheet Financials | |
$7.57M |
|
$0.27M |
|
$3.40M |
|
$10.96M |
|
$2.91M |
|
$0.57M |
|
$0.78M |
|
$3.68M |
|
$7.28M |
|
$5.16M |
|
$7.28M |
|
4.50M |
|
| Cash Flow Statement Financials | |
$-9.33M |
|
$-0.06M |
|
$14.73M |
|
$1.11M |
|
$6.45M |
|
$5.34M |
|
$0.67M |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
2.60 |
|
-- |
|
-- |
|
0.07 |
|
0.11 |
|
43.49% |
|
-196.94% |
|
|
EBIT Margin |
-196.94% |
-- |
|
-196.78% |
|
-196.98% |
|
$-9.39M |
|
-- |
|
-- |
|
-- |
|
0.15 |
|
16.81 |
|
2.94 |
|
30.62 |
|
-43.11% |
|
-60.85% |
|
-28.62% |
|
-39.96% |
|
$1.62 |
|
$-5.46 |
|
$-5.42 |
|